Simon T.P. Ridgway Sells 450,000 Shares of Medgold Resources Corp (CVE:MED) Stock

Medgold Resources Corp (CVE:MED) Director Simon T.P. Ridgway sold 450,000 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of C$0.06, for a total transaction of C$27,000.00. Following the completion of the transaction, the director now directly owns 2,484,107 shares in the company, valued at C$149,046.42.

Simon T.P. Ridgway also recently made the following trade(s):

  • On Monday, November 11th, Simon T.P. Ridgway purchased 10,000 shares of Medgold Resources stock. The stock was bought at an average cost of C$0.06 per share, for a total transaction of C$600.00.
  • On Thursday, November 7th, Simon T.P. Ridgway purchased 40,000 shares of Medgold Resources stock. The stock was bought at an average cost of C$0.06 per share, for a total transaction of C$2,400.00.

Shares of CVE:MED opened at C$0.06 on Thursday. The company’s 50-day moving average is C$0.07 and its 200 day moving average is C$0.10. The company has a market capitalization of $6.16 million and a P/E ratio of -4.58. Medgold Resources Corp has a fifty-two week low of C$0.06 and a fifty-two week high of C$0.17.

About Medgold Resources

Medgold Resources Corp., an exploration stage company, engages in the acquisition and exploration of resource properties primarily in Serbia. It explores for gold, silver, and precious and base metals. The company holds 100% interest in the Tlamino project that comprises a block of two contiguous claims, including Donje Tlamino and Surlica-Ducat totaling 192 square kilometers; and five granted exploration licenses covering an area of approximately 570 square kilometers located in the Serbo-Macedonian Massif belt, Serbia.

Read More: What Is An Exchange-Traded Fund (ETF)?

Receive News & Ratings for Medgold Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medgold Resources and related companies with MarketBeat.com's FREE daily email newsletter.